Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Gulf War Illness
Interventions
DIETARY_SUPPLEMENT

Curcumin

"Curcumin (chemical C21H20O6) is derived from turmeric (Curcuma longa) root extract, standardized to contain 95% curcuminoids. The greatest obstacle with curcumin is its poor natural bioavailability. To help circumvent that issue, a piperazine is included as black pepper 5.3mg (Piper nigrum) fruit extract standardized to 95% piperine. The botanical we are using is provided by Pure Encapsulations. Curcumin being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug.~100 participants will be randomized to receive curcumin. Participants will receive placebo, low-dose (500 mg/day), medium-dose (1000 mg/day), and/or high dose (2000 mg/day) curcumin in a randomized order."

DIETARY_SUPPLEMENT

Resveratrol

"Resveratrol (chemical C14H12O3) is provided as 99% Pure Trans-Resveratrol (MegaResveratrol) from polygonum cuspidatum root). Resveratrol being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug.~100 participants will be randomized to receive resveratrol. Participants will receive placebo, low-dose (250 mg/day), medium-dose (500mg/day), and/or high dose (1000mg/day) resveratrol in a randomized order."

DIETARY_SUPPLEMENT

Stinging Nettle

"Stinging nettle is derived from nettle (Urtica spp) leaf. The botanical we are using is provided by Pure Encapsulations. Stinging Nettle being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug.~100 participants will be randomized to receive stinging nettle. Participants will receive placebo, low-dose (435mg/day), medium-dose (870mg/day), and/or high dose (2610mg/day) stinging nettle in a randomized order."

Trial Locations (1)

35233

RECRUITING

The University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Congressionally Directed Medical Research Programs

FED

lead

University of Alabama at Birmingham

OTHER